The global Intravenous Immunoglobulin (IVIG) Market, which was valued at USD 11.2 billion in 2021, is poised for significant growth. With an estimated compound annual growth rate (CAGR) of 7.3% from 2022 to 2031, the market is expected to reach USD 20.5 billion by the end of the forecast period. The growing demand for immunotherapy treatments and the increasing prevalence of chronic and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian